000 | 01422 a2200397 4500 | ||
---|---|---|---|
005 | 20250518090034.0 | ||
264 | 0 | _c20210421 | |
008 | 202104s 0 0 eng d | ||
022 | _a1879-016X | ||
024 | 7 |
_a10.1016/j.pharmthera.2020.107516 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLiu, Xiaohua | |
245 | 0 | 0 |
_aMedulloblastoma: Molecular understanding, treatment evolution, and new developments. _h[electronic resource] |
260 |
_bPharmacology & therapeutics _c06 2020 |
||
300 |
_a107516 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
650 | 0 | 4 |
_aCerebellar Neoplasms _xdrug therapy |
650 | 0 | 4 | _aClinical Decision-Making |
650 | 0 | 4 | _aEpigenesis, Genetic |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aGenetic Heterogeneity |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMedulloblastoma _xdrug therapy |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 | _aPrecision Medicine |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aDing, Chunyong | |
700 | 1 | _aTan, Wenfu | |
700 | 1 | _aZhang, Ao | |
773 | 0 |
_tPharmacology & therapeutics _gvol. 210 _gp. 107516 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pharmthera.2020.107516 _zAvailable from publisher's website |
999 |
_c30680193 _d30680193 |